Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07315165 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Primary completion date: Sep 2030 to Oct 2030 · Completion date: Apr 2031 to May 2031 · Start date changed from estimate of Jul 3, 2026 to Jul 22, 2026 · 3 morev4 Show 6 more changesShow less
    • Primary completion date: Sep 2030 to Oct 2030
    • Completion date: Apr 2031 to May 2031
    • Start date changed from estimate of Jul 3, 2026 to Jul 22, 2026
    • Secondary endpoints revised (10)
    • Study description expanded, about 180 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  2. Start date: Apr 2026 to Jul 3, 2026v3
  3. Secondary endpoints: 9 to 10v2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled phase II trial which will enroll 112 patients with a diagnosis of a blood cancer or a serious blood disorder who plan to undergo an allogenic hematopoietic stem cell transplant using any conditioning regimen or graft source. Eligible patients will be randomized to receive standard of care (e.g., initiation of supplemental nutrition when oral intake declines) versus enteral nutrition via enteral feeding tube starting on day +1 post-transplant for at least 7 days, usually until engraftment.
Trial Details
NCT Number NCT07315165
Lead Sponsor University of Nebraska
Conditions Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov